Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT Boost and Long-Term ADT for High-Risk Prostate Cancer
NCT02064036Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Jun 2013
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of leuprolide and bicalutamide in prostate adenocarcinoma, sponsored by University of California, Davis. Primary endpoint: Tumor Assessment at 24 months. Started Jun 2013; status: completed.
02
Drugs
leuprolidebicalutamide
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT02064036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064036.